A randomized controlled trial demonstrating sustained benefit of autologous matrix-induced chondrogenesis (AMIC®) over microfracture: 10-year follow-up
European Journal of Orthopaedic Surgery & Traumatology · 17.04.2024 · 34 (5) · 2429-2437
DOI: 10.1007/s00590-024-03948-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 17.04.2024. Verfasst von Martin Volz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sportklinik Ravensburg, Ravensburg, Germany. Hauptthemen laut MEDLINE: Chondrogenesis, Arthroplasty, Subchondral, Cartilage, Articular. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Geistlich Pharma, Universität Regensburg.
Abstract (Originalsprache)
Purpose
Autologous matrix-induced chondrogenesis (AMIC ® ) and microfracture are established treatments for focal chondral defects in the knee, but there are little clinical data concerning these procedures over the long term. This study evaluates the outcomes of AMIC ® compared to microfracture over 10-year follow-up.
Methods
Forty-seven patients were randomized and treated either with MFx ( n = 13), sutured AMIC ® ( n = 17) or glued AMIC ® ( n = 17) in a prospective, randomized, controlled multicentre trial. The Modified Cincinnati Knee Score, a visual analogue scale for pain and MOCART score were used to assess outcomes over 10 years post-operatively.
Results
All treatment arms improved in the first 2 years, but a progressive and significant deterioration in scores was observed in the MFx group, while both AMIC ® groups remained stable. MOCART scores were comparable between groups.
Conclusion
The AMIC ® procedure results in improved patient outcomes in comparison with microfracture up to 10 years following surgery for the repair of focal chondral defects in the knee. ClinicalTrials.gov Identifier: NCT02993510
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sportklinik Ravensburg, Ravensburg, Germany.
- Department of Orthopedic Surgery, Asklepios Clinical Center Bad Abbach, University of Regensburg, Kaiser-Karl V.-Allee 3, 93077, Bad Abbach, Germany.
- Radiologische Allianz, Hamburg, Germany.
- Department of Orthopedic Surgery, Asklepios Clinical Center Bad Abbach, University of Regensburg, Kaiser-Karl V.-Allee 3, 93077, Bad Abbach, Germany. s.anders@asklepios.com.
Förderung
- Geistlich Pharma
- Universität Regensburg
Zitieren
APA
Volz, M., Schaumburger, J., Gellißen, J., Grifka, J., & Anders, S. (2024). A randomized controlled trial demonstrating sustained benefit of autologous matrix-induced chondrogenesis (AMIC®) over microfracture: 10-year follow-up. European Journal of Orthopaedic Surgery & Traumatology, 34(5), 2429-2437. https://doi.org/10.1007/s00590-024-03948-0
Vancouver
Volz M, Schaumburger J, Gellißen J, Grifka J, Anders S. A randomized controlled trial demonstrating sustained benefit of autologous matrix-induced chondrogenesis (AMIC®) over microfracture: 10-year follow-up. European Journal of Orthopaedic Surgery & Traumatology. 2024;34(5):2429-2437. doi:10.1007/s00590-024-03948-0
BibTeX
@article{Volz2024,
author = {Volz, Martin and Schaumburger, Jens and Gellißen, Jörg and Grifka, Joachim and Anders, Sven},
title = {A randomized controlled trial demonstrating sustained benefit of autologous matrix-induced chondrogenesis (AMIC®) over microfracture: 10-year follow-up},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
volume = {34},
number = {5},
pages = {2429--2437},
doi = {10.1007/s00590-024-03948-0}
}
EUVIMED